HeartBeam (BEAT) Stock Soars After FDA Clearance: Latest News, Forecasts and Analyst Views
As of December 11, 2025, HeartBeam, Inc. (NASDAQ: BEAT) has abruptly moved from obscure micro‑cap to one of the hottest tickers in medtech, after winning a pivotal U.S. FDA clearance for its cable‑free, at‑home 12‑lead ECG synthesis software. The stock